Riskpilot← Back to searchSign inGet full accessARCUS VITA AS
ASActiveOrg 992145870Birkebeinervegen 21, 2316 HamarRetail sale of medical and orthopaedic goods · NACE 4774Est. 20085 employees
Revenue 2024
NOK 5,5M
+17% vs 2023
EBITDA margin
2.2%
-18% vs 2023
Equity ratio
-46.3%
Financial strength
Net profit 2024
NOK -142K
-288% vs 2023
| Revenue | NOK 5,5M | +17% |
| EBITDA | NOK 121K | -18% |
| Net profit | NOK -142K | -288% |
| Total assets | NOK 2,4M | +28% |
| Equity | NOK -1,1M | -15% |
| Employees | 5 | — |
Legal name
ARCUS VITA AS
Org number
992145870
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
8. januar 2008
Share capital
NOK 333 940
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Salg og markedsføring av nisjeprodukter innen helsesektoren.
Address
Birkebeinervegen 21, 2316 Hamar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 122 | 7 320 | 4 474 | 4 718 | 5 502 |
| Staff expenses | −2 638 | −2 684 | −1 499 | −952 | −1 126 |
| EBITDA | −770 | −962 | −590 | 147 | 121 |
| Depreciation & amort. | −26 | −14 | −9 | −9 | −33 |
| EBIT | −796 | −977 | −599 | 138 | 88 |
| Net financials | −229 | −146 | −116 | −175 | −229 |
| Profit before tax | −1 025 | −1 123 | −716 | −36 | −142 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 025 | −1 123 | −716 | −36 | −142 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 320 | 3 518 | 1 807 | 1 847 | 2 361 |
| Equity | 979 | −200 | −915 | −952 | −1 093 |
| Long-term debt | 4 289 | 715 | 863 | 546 | 0 |
| Short-term debt | 1 052 | 3 003 | 1 860 | 2 252 | 3 002 |
| Total debt | 5 341 | 3 718 | 2 722 | 2 799 | 3 454 |
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
20202024
Equity ratio
-46.3%
This company
38.2%
Market median
-221% vs market
20202024
Return on equity
-14151100.0%
This company
18.4%
Market median
-76908252% vs market
20202024
Net profit margin
-2.6%
This company
8.1%
Market median
-132% vs market
20202024
Asset turnover
2.33×
This company
1.12×
Market median
+108% vs market
20202024
Debt / equity
3.16×
This company
0.62×
Market median
-410% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GR Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (1) | ||
GA Chief Executive Officer | Chief Executive Officer | 2020 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2021 – 2024 | |
| Board of Directors | 2021 – 2021 | |
| Chairman | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2023 | |
| Company | 50% | 50% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Quell Holding As
ARCUS VITA AS Board members of ARCUS VITA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gitte Rytterager | Chief Executive Officer | 0 companies |
| Geir Alvsvåg | Chief Executive Officer | 0 companies |
| Roy Martin Øyjord | Chairman | 0 companies |
| Kjell Larsen | Board of Directors | 0 companies |
| Terje Kristian Berntzen | Chairman | 0 companies |